BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15852252)

  • 1. Epidemiology of lymphoma development in patients with rheumatoid arthritis.
    Ekbom A
    Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):28-30. PubMed ID: 15852252
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.
    Symmons DP; Silman AJ
    Arthritis Rheum; 2004 Jun; 50(6):1703-6. PubMed ID: 15188344
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis and the lymphoma link. It's the disease's chronic, severe inflammation, not the treatment, that causes the risk.
    Health News; 2006 Jul; 12(7):8-9. PubMed ID: 16856241
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Wolfe F; Michaud K
    Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate treatment and mortality in rheumatoid arthritis.
    Sibilia J; Mariette X
    Lancet; 2002 Oct; 360(9339):1096-7. PubMed ID: 12384011
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
    Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
    Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF antagonist safety in rheumatoid arthritis: updated evidence from observational registries.
    Nasir A; Greenberg JD
    Bull NYU Hosp Jt Dis; 2007; 65(3):178-81. PubMed ID: 17922666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
    Kaplan MJ
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphoma and rheumatoid arthritis--again.
    Symmons DP
    Rheumatology (Oxford); 2007 Jan; 46(1):1-2. PubMed ID: 16936333
    [No Abstract]   [Full Text] [Related]  

  • 10. EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment.
    Chim CS; Pang YY; Ooi GC; Mok MY; Shek TW
    Haematologica; 2006 Aug; 91(8 Suppl):ECR31. PubMed ID: 16923515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing dimensions of rheumatoid arthritis and its treatment.
    Harris ED
    Bull World Health Organ; 2003; 81(9):631. PubMed ID: 14710503
    [No Abstract]   [Full Text] [Related]  

  • 12. B-cell lymphoma of the larynx in a patient with rheumatoid arthritis.
    Patiar S; Ramsden JD; Freeland AP
    J Laryngol Otol; 2005 Aug; 119(8):646-8. PubMed ID: 16102224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies in patients with rheumatoid arthritis.
    Koivuniemi R; Paimela L; Suomalainen R; Leirisalo-Repo M
    Scand J Rheumatol; 2011 Mar; 40(2):154-5. PubMed ID: 20858144
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and risks of biological agents: lymphomas.
    van Vollenhoven RF
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S122-5. PubMed ID: 15552525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
    Quartuccio L; De Re V; Fabris M; Marzotto A; Franzolini N; Gasparotto D; Caggiari L; Ferraccioli G; Scott CA; De Vita S
    Haematologica; 2006 May; 91(5):691-4. PubMed ID: 16670074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antirheumatic drugs and the risk of tuberculosis.
    Mines D; Novelli L
    Clin Infect Dis; 2007 Feb; 44(4):619-20; author reply 620-1. PubMed ID: 17243073
    [No Abstract]   [Full Text] [Related]  

  • 18. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment.
    Thonhofer R; Gaugg M; Kriessmayr M; Neumann HJ; Erlacher L
    Ann Rheum Dis; 2005 Jul; 64(7):1098-9. PubMed ID: 15958773
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis.
    Lorenzo M
    Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.